Results 201 to 210 of about 150,672 (260)

Eliciting antitumor immunity via therapeutic cancer vaccines. [PDF]

Cell Mol Immunol
Peng K, Zhao X, Fu YX, Liang Y.
europepmc   +1 more source

Detecting communities when order and direction matter in social network analysis

Canadian Journal of Statistics, EarlyView.
Abstract A novel algorithm combining both node degree and edge betweenness (node degree+edge betweenness) is developed to highlight gradients in connectivity. It identifies communities within complex directed graphs. These are networks that are composed of actors who have ties that originate and end at themselves (self‐loops).
Benjamin Smith, Tyler Pittman, Wei Xu
wiley   +1 more source

Therapeutic Cancer Vaccines in Colorectal Cancer: Platforms, Mechanisms, and Combinations. [PDF]

Cancers (Basel)
Gallio C, Esposito L, Passardi A.
europepmc   +1 more source

Intravenous Lipopolysaccharide Challenge in Healthy Participants Reveals Pharmacodynamic Markers in Blood and Bone Marrow for Early‐Phase Oncology Drug Development

Clinical Pharmacology &Therapeutics, EarlyView.
Demonstrating pharmacological effects in early‐phase oncology clinical trials remains challenging, largely due to the lack of robust pharmacodynamic markers. Lipopolysaccharide (LPS) is used as an immune challenge agent in healthy participants to study drugs for autoimmune conditions.
Igor Radanović, Ingrid Tomljanović, Wieke H. Grievink, Diana R. Pereira, Michelle Osse, Peter van Balen, Maria J. Juachon, Marieke L. de Kam, Lisa Pagan, Manon A.A. Jansen, Matthijs Moerland, Jacobus J. Bosch   +11 more
wiley   +1 more source

A systematic review of the efficacy of cancer vaccines in advanced breast cancer. [PDF]

Breast Cancer
Charalampopoulou A, Filippatos C, Malandrakis P, Zagouri F, Gavriatopoulou M, Ntanasis-Stathopoulos I.   +5 more
europepmc   +1 more source

Extended High‐Risk HPV Genotyping With BD Onclarity Enhances Anal Cancer Screening Among High‐Risk Populations: A Cross‐Sectional Study

Diagnostic Cytopathology, EarlyView.
ABSTRACT Background Anal cancer rates are rising among women, immunocompromised individuals, and Men who have sex with Men (MSM), independent of HIV status. While high‐resolution anoscopy remains the diagnostic standard, limited access has increased interest in alternative screening.
Daisy Maharjan, Joshua Waters, Melissa Randolph, Benjamin Shuler, Julie Borum, Sheila Segura   +5 more
wiley   +1 more source

A Comprehensive Review of Nanoadjuvants in Cancer Vaccines and Their Immunomodulatory Role and Clinical Applications. [PDF]

Arch Razi Inst
Mahan H, Neda M, Elahe DN, Nilufar HS, Mahsa F, Farjad Z, Amirhossein DD, Shiva D.   +7 more
europepmc   +1 more source

Engineering pyroptotic vesicles as personalized cancer vaccines. [PDF]

Nat Nanotechnol
Li Z, Wang Y, Mo F, Wolter T, Hong R, Barrett A, Richmond N, Liu F, Chen Y, Yang X, Dempsey L, Hu Q.   +11 more
europepmc   +1 more source

Strategic Advances in Targeted Delivery Carriers for Therapeutic Cancer Vaccines. [PDF]

Int J Mol Sci
Wu J, Liang J, Zhang Y, Dong C, Tan D, Wang H, Zheng Y, He Q.   +7 more
europepmc   +1 more source

Personalized Cancer Vaccines in Combination Therapies: Current Status and Future Prospects. [PDF]

Asian Pac J Cancer Prev
Rukhayya F, Katta L, Ghori HK, Kattela S, Parvez M, Posani S, Parmar MP, Jatin F, Sahu S, Younas S.   +9 more
europepmc   +1 more source